Understanding a national increase in COVID-19 vaccination intention, the Netherlands, November 2020-March 2021 by Sanders, Jet G. et al.
1www.eurosurveillance.org
Rapid communication
Understanding a national increase in COVID-19 
vaccination intention, the Netherlands, November 
2020–March 2021
Jet G. Sanders1,2 , Pita Spruijt¹ , Mart van Dijk¹ , Janneke Elberse¹ , Mattijs S. Lambooij¹ , Floor M. Kroese1,3 , Marijn de Bruin1,4
1. Corona Behavioural Unit, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
2. Department of Psychological and Behavioural Science, London School of Economics and Political Sciences, London, United 
Kingdom
3. Department of Social, Health and Organizational Psychology, Utrecht University, Utrecht, The Netherlands
4. IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
Correspondence: Jet G. Sanders (jet.sanders@rivm.nl)
Citation style for this article: 
Sanders Jet G., Spruijt Pita, van Dijk Mart, Elberse Janneke, Lambooij Mattijs S., Kroese Floor M., de Bruin Marijn. Understanding a national increase in COVID-19 
vaccination intention, the Netherlands, November 2020–March 2021. Euro Surveill. 2021;26(36):pii=2100792.
Article submitted on 10 Aug 2021 / accepted on 09 Sep 2021 / published on 09 Sep 2021
The intention to get the COVID-19 vaccine increased 
from 48% (November 2020) to 75% (March 2021) as 
national campaigning in the Netherlands commenced. 
Using a mixed method approach we identified six vac-
cination beliefs and two contextual factors informing 
this increase. Analysis of a national survey confirmed 
that shifting intentions were a function of shifting 
beliefs: people with stronger intention to vaccinate 
were most motivated by protecting others and reo-
pening society; those reluctant were most concerned 
about side effects.
Mass vaccination against coronavirus disease (COVID-
19) is an important tool to control the pandemic and 
recover from its consequences [1]. Vaccine hesitancy 
may hamper the effectiveness of vaccination pro-
grammes [2]. Knowledge of which factors are associated 
with vaccination hesitancy can guide efforts towards 
developing effective campaigns to increase acceptance 
of the COVID-19 vaccine and maximise uptake [3-5]. A 
nationally representative survey in the Netherlands 
showed that vaccination intention increased substan-
tially from 48% in November 2020 to 75% in January 
2021 (Figure 1) when the national COVID-19 vaccination 
campaign commenced [6,7]. Our aim was to determine 
which psychosocial factors were associated with this 
shift in intentions to get the COVID-19 vaccination. 
Beliefs and intentions
We identified reasons for different vaccination inten-
tions through open-ended responses to a question 
about reasons behind one’s vaccination intention in a 
national cohort survey and qualitative interviews.
As part of a six-weekly national cohort survey we asked 
64,170 participants to indicate their vaccination inten-
tion during Wave 8 of the survey in November 2020 [8]. 
All 64,170 participants (see Supplementary materials 
1 for demographic details) provided a reply through 
the closed-ended question on their vaccination inten-
tion (the exact wording of this question was: “If there 
is a vaccine against the coronavirus, will you get vac-
cinated?”); if participants indicated that they intended 
to vaccinate (n = 32,471) or did not intend to vaccinate 
(n = 7,530) they were shown an adjacent and optional 
open ended question asking them to write about their 
reasons for their vaccination intention. Of these 11.7% 
(n = 7,106) provided a response to the open-ended 
question. We analysed all the open-ended responses 
provided by the 2,292 participants who indicated to 
have the intention to get vaccinated and all open-ended 
responses by the 2,393 participants with no intention 
to get vaccinated (see Supplementary materials 2 for 
details).
Next, we conducted (in January 2021) 60 semi-struc-
tured telephone interviews over a 4-day period among 
participants who indicated to be uncertain or to have 
no intention to get vaccinated in Wave 9 of the cohort 
study in December 2020 (see Supplementary materials 
3 for methodological and participant details). The aim 
of the interviews was to capture concerns and beliefs 
for this population in a time where we observed inten-
tional switching. Interviews were transcribed verbatim 
(under supervision of PS) and thematic analysis [9] was 
performed (by PS and JE; see Supplementary materi-
als 4 for results). Insights were pooled across the two 
datasets.
We identified six common beliefs about COVID-19 vac-
cination: (i) concerns about short-term side effects; (ii) 
concerns about long-term side effects; (iii) personal 
vaccination will protect others (this includes a sense of 
2 www.eurosurveillance.org
moral duty); (iv) personal vaccination will protect one-
self; (v) trust in science or institutions; (vi) vaccination 
is key to reopening society (Table 1).
While the choice to get a vaccine is dichotomous, we 
found that vaccination intention functioned on a con-
tinuum, coupled with distinctive belief profiles: at the 
reluctant end barriers dominated (Beliefs 1 and 2). 
As the share of favourable arguments (Beliefs 3−6) 
increased respondents’ intentions moved from ‘prob-
ably not’, to ‘probably’, and finally to ‘definitely’ get-
ting vaccinated.
Next to these six beliefs, we observed two contextual 
factors that played an important role in changing inten-
tions i.e. the social context and cue to action.
With regards to social context, participants frequently 
mentioned not wanting to be the first to get vaccinated 
(“I am not a guinea pig“). For some participants rising 
vaccination rate was seen as a driver to getting vacci-
nated (a signal for safety and effectiveness), whilst for 
others this was seen as a barrier (if high  “I no longer 
need to do it“). The latter can be linked to the ‘free-
riding’ phenomenon [10]).
For cue to action, some participants postponed their 
decision until they would receive their official invitation 
(in the form of a letter). Beliefs were updated periodi-
cally, informed by (non-persuasive) pro-choice infor-
mation on side effects by public individuals. National 
campaigns and targeted media reports by medical 
experts, or personal conversations with health profes-
sionals were named as decisive messengers.
Of the 60 interviewees, 18 (30%) had changed their 
vaccination intention from not intending to or uncertain 
of getting vaccinated, to intending to get vaccinated 
between survey completion and their interview (2-week 
gap). This was an indication that vaccination intention 
might not be fixed and might change over time.
Beliefs predicting shifts in intention
The six beliefs related to COVID-19 vaccination and two 
contextual factors were incorporated into Wave 10 of 
the cohort survey (February 2021). Vaccination beliefs 
and contextual factors were assessed using single 
item measures (see  Table 1  for exact statements and 
response options). Descriptive statistics for the 52,400 
respondents confirmed that vaccination beliefs display 
on a continuum (Figure 2).
To identify which beliefs were most relevant in the con-
text of COVID-19 vaccination intention switching, we 
conducted a multinomial logistic regression of the vac-
cination beliefs (continuous variables) and contextual 
factors (social context as continuous, cue to action as 
dichotomous) in Wave 10 (February 2021) for partici-
pants who had been uncertain at Wave 10 and switched 
to ‘yes’ or ‘no’ relative to those who did not (‘still 
uncertain’) in Wave 11 (March 2021; n = 3,383; Table 2). 
Response options for vaccination beliefs and the social 
context statements were ordinal on a 1−5 Likert scale. 
These were incorporated into the regression model as 
continuous variables.
Those who switched from uncertain in their inten-
tion to get vaccinated (n = 1,197) had less uncertainty 
about short-term (adjusted Odds Ratio (aOR) = 0.89) 
or long-term side effects (aOR = 0.90), reported higher 
institutional trust (aOR = 1.31) and stronger belief 
that vaccination protects others (aOR = 1.56) in the 
wave prior to their switch, relative to those who were 
still in doubt (n = 1,928). They also reported hav-
ing more people in their social environment who had 
been vaccinated (aOR = 1.15). Those who switched 
from being uncertain to having no intention to get 
vaccinated (n = 258) oppositely report lesser institu-
tional trust (aOR = 0.71) and weaker belief that vacci-
nation protects others (aOR = 0.80) in the wave prior 
to their switch, than those who remained in doubt. As 
Figure 1
Intention to get vaccinated against COVID-19 according 







































a The national trend survey represents a cross-sectional 
representative sample of the Dutch population. Samples ranged 
from 4,890 and 5,262 per Wave (average 5,060) with a response 
rate of 52%. All participants who completed the survey, 
responded to the question. Confidence intervals fall within 1.5% 
of the average. Data was retrieved and adapted from: https://
coronadashboard.government.nl/landelijk/vaccinaties.
b Participants were asked about their vaccination status and 
intentions if they had not yet been vaccinated. Participants were 
invited to vaccinate over this time-period using a staggered roll-
out according to prioritisation criteria such as age, health status 
and essential worker status. Vaccination rates increased over 
time. To represent pro-vaccination intention accurately for the 
Dutch population, we use a combined outcome variable, which 
incorporates (i) those with a positive vaccination intention and; 
(ii) those who have already been vaccinated (reflecting a pro-
vaccination intention).
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Potential side effects: “First I want 
to know if there are really no side-
effects.” 
 
Participants indicated that they did 
not wish to get vaccinated because 
of their physical condition “I have 
allergies.”, 
 
“I always get sick from 
vaccinations.”, “I can’t in my 
current condition.”
Na
Current side effects, for example 
in relation to medication use. 
Recommendation from health 
professional were also mentioned 
as deciding factor: “I let myself be 
guided by the recommendation of 
my cardiologist. I am not against 
vaccinations, but I am also a heart 
patient and any potential side- effects 
are, therefore of critical importance.”
I am scared of potential 













As a result from rapid development 
participants reported that 
long term consequences are a 
concern, in particular in relation 
to fertility “We don’t know about 
pregnancy yet.”; Participants 
mentioned that they preferred 
to wait a bit longer until more is 
known.
Na
Long-term consequences: “If it is only 
effective for three months, then I won’t 
get it”. Examples: medications which 
were discovered to have negative 
side-effects later. Some women 
expressed concerns about potential 
effect on fertility. 
 
Others employed the wait and see 
approach: one is inclined not to 
vaccinate until more knowledge on 
long-term side effects gives greater 
confidence in the vaccine.
I am scared of possible 
unknown long-term 













loved ones was an 
important reason “It feels 
safer for my husband” “my 
parents are old”; “to protect 
my family” 
 
Some people noted 
protection of others as a 
moral duty 
 
“It’s just important”; “I am 
doing this for the social 
good”
Na
To protect others, including 
for the greater good. 
 
“I want the vaccine to 
contribute to protecting 
others.”
 Na
If I am vaccinated, I 












Protect oneself for fear of 
getting sick or risk trade-off 
between COVID-19 and 
vaccination “Better safe 
than sorry.”
No need to protect oneself. In 
risk trade off, no or little fear 
of illness “Coronavirus is not 
dangerous for me.”; “Chances that 
I get ill are small.”; “I prefer getting 
corona than getting a jab.”
 
 
“By getting vaccinated I 
protect myself and regain 
some freedom.”
 Na
If I get vaccinated, I 









Trust in science 
or institutions
Trust in national 
institutions “If it’s approved 




No different from other 
vaccines.
Generalised lack of trust “I 
don’t trust it.”; “No government 
will invade my body.”; Speed 
of development could not have 
allowed for appropriate testing: 
“I think it went too fast.”; “It was 
brought to the market too quickly.”
Trust in other 
organisations. Comparison 
with other vaccines: “I 
wouldn’t usually question 
this.”; confidence that 
government acts for the 
good of society and that the 
scientific community acts 
responsibly and carefully.
Concerns over rapid development 
raises questions about safety of the 
vaccine and potential (long-term) 
side effects; distrust of the mRNA 
vaccines, as this is a new type of 
vaccine.
If the vaccine has been 
approved on the Dutch 





disagree; neutral; agree; 
completely agree
COVID-19: coronavirus disease; Na: not applicable; TV: television.
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key to reopening 
society
Wanting to get vaccinated 
to fight the pandemic 
“It will help to slow 
the virus and stop the 
pandemic.”; or to reopen 
society: “So we can go back 
to normal.”
 Na
Contributing to a way out 
of the crisis to be able to 
have more social contacts, 
hug or take part in non-
essential activities again.
Na
If I get vaccinated, I 
contribute to a way out of 













vaccination rate works as a 
driver (greater confidence 
in safety/effectiveness) 
 
“The more people that are 
vaccinated, the safer it is for 
me to also be vaccinated.”
Increasing/high vaccination rate 
works as a barrier. If already high: “I 
no longer need to do it.”. This is also 
known as “free-riding”.
Most of my friends 
and family have been 
vaccinated against 
corona or are planning 




disagree; neutral; agree; 
completely agree
Contextual factor 
2: Cue to action
Invitation letter: “I am 
being asked to.”; or through 
trusted messengers: “My 
doctor says I should.”
 Na
Invitation letter: “I will 
make my decision when 
it becomes relevant.”; 
information from trusted 
individuals (medical 
experts), e.g. on TV. 
 
“If I see a reputable doctor 
on TV who answers a 
number of questions, then 
it makes me more relaxed 
and, despite my doubts, 
also gives me confidence to 
be vaccinated.”
 Na
Have you already 
received an invitation, 
or are you due to be 
vaccinated against the 
coronavirus?b 
 
Response options: Yes; 
no; I don’t knowc.
COVID-19: coronavirus disease; Na: not applicable; TV: television.
a Wording of the statements and questions used in the national survey was adjusted in language to accommodate colloquial referral to 
COVID-19.
b We noted both the invitation letter and trusted public messengers as a salient environmental cues, however opted to incorporate only 
an item on invitation letters into the cohort survey. This was for two reasons: we had restrictions in the number of items that could be 
incorporated, and campaigning and influence of trusted messengers we believed may be harder to retrace or identify for the individual. We 
therefore opted to incorporate only the cue to action of the invitation letter as a single item statement in the cohort survey.
c Only 26 participants answered “I don’t know”. Due to the small sample size this group was removed from the analysis and the variable was 
entered as a dichotomous variable ‘yes/no’ in the regression model.
Table 1b
Dominant beliefs and contextual factors in relation to COVID-19 vaccine intention identified in open-ended responses and 
interviews distilled into statements used in subsequent waves of the national cohort survey, the Netherlands, November and 
December 2020
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expected from the qualitative results, in both groups 
the switch in vaccination intention related strongly to 
receiving the invitation to get vaccinated (aOR = 4.25 
and aOR = 1.64).
Ethical statement
The study does not meet the requirement as laid down 
in the Law for Research Involving Human Subjects 
(WMO) and was therefore exempted from formal 
ethical review. Informed consent was provided by all 
participants.
Discussion
Based on these findings, and its co-occurrence with 
the national increase in pro-vaccination intention in the 
Netherlands, we put forward three pillars for national 
pro-vaccination informational campaigns.
Firstly, as people’s beliefs inform their intentions, infor-
mational campaigns should provide reliable (not per-
suasive) information for informed autonomous choice. 
This may contain individually tailored advantages (e.g., 
protective benefits toward self/others, or a staged 
release of the COVID-19 measures). The campaigns 
may also benefit from presenting disadvantages of 
vaccination (e.g., risks of side effects) in trade-off with 
the risks of not vaccinating against COVID-19. Finally, 
campaigns may benefit from information on how a vac-
cine was developed so quickly and that no compro-
mises were made on quality and procedure should also 
be communicated and which steps are being taken to 
monitoring it’s safety to share these transparently [11].
Secondly, people may periodically update their beliefs 
and intentions and it is important to provide support 
throughout the choice process. This may concern infor-
mation about vaccination through reliable channels 
i.e., medical experts on mass or social media, or tar-
geted very brief advice (VBA) from general practition-
ers or professional patient associations [12]. Such a 
conversation with a reliable advisor or doctor may be 
even more effective if local trust in government (and 
its institutions) is low [13]. Accurate and up-to-date 
information on numbers of people who have been 
vaccinated and adverse events should be provided 
throughout the vaccination campaign. Getting vaccina-
tion should be linked to other beliefs, such as the duty 
to protect others or getting out of crisis.
Thirdly, people may have the intention, but not fol-
low through (also called the intention–behaviour gap 
[21,22];) so in addition to a focus on people’s beliefs 
vaccine uptake needs to be easy and accessible. This 
may be realised through use of localised or mobile 
vaccination sites [14,15] with walk-in or drive-through 
appointments [16,17], sending reminder messages or 
letters to get vaccinated (cue to action; consider tim-
ing, intensity and content of messages [20]), or by 
facilitating peer-to-peer social media sharing to set the 
social norm [18,19].
Conclusions
In March 2021, approximately one in five people in 
the Netherlands reported having no intention or being 
unsure of whether to get vaccinated against COVID-19. 
Figure 2
Percentage of participants who indicated to ‘agree’ or ‘completely agree’ for the vaccination belief statements separated by 
(who intends to get) vaccinated (yellow), those who do not (red) and those who are in doubt (blue), national cohort survey 
Wave 10, the Netherlands, February 2021 (n = 52,400)
0 25 50 75 100
Most of my friends and family have been vaccinated
against corona or are planning to do so
If I am vaccinated, I protect others from the
coronavirus
I am scared of possible unknown long-term effects
of the vaccine
If I get vaccinated, I contribute to a way out of the
corona crisis for the Netherlands
If the vaccine has been approved on the Dutch
market, I believe that it is safe
I am scared of potential side effects of the vaccine
If I get vaccinated, I am protected from the
coronavirus
% of participants that agree
(Intends to get) vaccinated Does not intend to get vaccinated In doubt
COVID-19: coronavirus disease.
Colloquial expressions were used in the belief statements to ease public understandings.
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As vaccine uptake is likely to be lower than vaccina-
tion intention, this is still worryingly high considering 
the impact of COVID-19 on day-to-day life. Our findings 
demonstrate that (i) vaccination intention functions on 
a spectrum and can change over time; (ii) the actual 
choice to get vaccinated or not happens at the point of 
official invitation; (iii) the directional shifts in intention 
can be predicted by patterns in beliefs and the social 
norm prior to the choice process. We expect that these 
patterns hold beyond the Dutch context, and possibly 
beyond this pandemic. Our results indicate that vacci-
nation campaigns could be a decision aid to those at a 
decision point and increase chances of reaching critical 
vaccination levels.
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Table 2
Multinomial logistic regression of vaccination beliefs and contextual factors for participants ‘uncertain’ at Wave 10 and who 
switched to ‘yes’ or ‘no’ relative to those who did not in Wave 11, national cohort survey, the Netherlands, February–March 
2021 (n = 3,383)
Beliefs (Wave 10)
Switched intention to get vaccinated 
(n = 1,197)
Switched intention to not get vaccinated 
(n = 258)
Adjusted OR 95% CI p value Adjusted OR 95% CI p value
I am scared of potential side effects of the vaccine. 0.89 0.80–0.98 0.02 1.02 0.86–1.21 0.83
I am scared of possible unknown long-term effects 
of the vaccine. 0.90 0.81–1.00 0.05 1.06 0.87–1.29 0.54
If I get vaccinated, I am protected from the 
coronavirus. 1.10 0.99–1.22 0.09 1.18 0.99–1.40 0.07
If I am vaccinated, I protect others from the 
coronavirus. 1.09 0.98–1.22 0.10 0.89 0.75–1.07 0.22
If the vaccine has been approved on the Dutch 
market, I believe that it is safe. 1.31 1.16–1.47 <.001 0.71 0.59–0.86 <.001
If I get vaccinated, I contribute to a way out of the 
corona crisis for the Netherlands. 1.56 1.39–1.76 <.001 0.80 0.67–0.96 0.02
Contextual factors
Most of my friends and family have been vaccinated 
against corona or are planning to do so (social 
context, Wave 10).
1.15 1.03–1.28 0.01 0.96 0.80–1.14 0.60
Have you received an invitation, or is your 
vaccination against the coronavirus due? Cue to 
action, Wave 11.
4.25 3.29–5.50 <.001 1.64 1.04–2.59 0.03
Sex
Female Reference
Male 1.04 0.87–1.25 0.68 0.88 0.63–1.21 0.42
Age
≥70 years old Reference
55–69 years old 0.71 0.54–0.94 <.001 0.71 0.41–1.22 0.22
40–54 years old 0.49 0.37–0.65 <.001 0.89 0.52–1.52 0.68
25–39 years old 0.40 0.29–0.55 <.001 1.27 0.73–2.21 0.40
16–24 years old 0.40 0.23–0.70 0.02 0.91 0.35–2.32 0.84
Education
Higher education Reference
Secondary education 1.04 0.87–1.24 0.65 1.34 1.00–1.79 0.05
Primary education or lower vocational education or 
no education 0.91 0.70–1.17 0.46 1.38 0.91-2.10 0.13
CI: confidence interval; OR: odds ratio.
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